- Home
- EWBC vs NBIX Comparison
EWBC vs NBIX Comparison
Compare EWBC & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EWBC
- NBIX
- Stock Information
- Founded
- EWBC 1998
- NBIX 1992
- Country
- EWBC United States
- NBIX United States
- Employees
- EWBC N/A
- NBIX N/A
- Industry
- EWBC Major Banks
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EWBC Finance
- NBIX Health Care
- Exchange
- EWBC Nasdaq
- NBIX Nasdaq
- Market Cap
- EWBC 11.8B
- NBIX 12.0B
- IPO Year
- EWBC 1999
- NBIX 1996
- Fundamental
- Price
- EWBC $91.20
- NBIX $123.02
- Analyst Decision
- EWBC Buy
- NBIX Strong Buy
- Analyst Count
- EWBC 13
- NBIX 20
- Target Price
- EWBC $105.92
- NBIX $163.20
- AVG Volume (30 Days)
- EWBC 770.3K
- NBIX 1.6M
- Earning Date
- EWBC 07-22-2025
- NBIX 05-05-2025
- Dividend Yield
- EWBC 2.63%
- NBIX N/A
- EPS Growth
- EWBC 5.55
- NBIX N/A
- EPS
- EWBC 8.38
- NBIX 2.96
- Revenue
- EWBC $2,407,834,000.00
- NBIX $2,412,600,000.00
- Revenue This Year
- EWBC $4.88
- NBIX $15.99
- Revenue Next Year
- EWBC $5.44
- NBIX $14.93
- P/E Ratio
- EWBC $10.88
- NBIX $41.60
- Revenue Growth
- EWBC 2.99
- NBIX 21.73
- 52 Week Low
- EWBC $68.27
- NBIX $84.23
- 52 Week High
- EWBC $113.95
- NBIX $157.98
- Technical
- Relative Strength Index (RSI)
- EWBC 53.31
- NBIX 62.85
- Support Level
- EWBC $88.26
- NBIX $117.59
- Resistance Level
- EWBC $93.00
- NBIX $125.63
- Average True Range (ATR)
- EWBC 1.83
- NBIX 2.98
- MACD
- EWBC -0.49
- NBIX -0.02
- Stochastic Oscillator
- EWBC 32.59
- NBIX 72.90
About EWBC East West Bancorp Inc.
East West Bancorp Inc operates in U.S. and Asia. The Bank provides range of personal and commercial banking services to individuals and businesses. In addition to offering traditional deposit products that include personal and business checking and savings accounts, money market, and time deposits, the Bank also offers foreign exchange, treasury management and wealth management services. The Bank has three operating segments, (1) Consumer and Business Banking, (2) Commercial Banking and (3) Treasury and Other. The company generates the majority of its revenue from the Commercial banking segment.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.